在过去几年中，癌症管理的多方面进展显著提高了生存率。在患者的肿瘤旅程中，他们可能会接受一个或多个可植入设备，用于输液、给药以及管理与癌症治疗相关的各种共病和并发症。这些设备相关感染是频繁和复杂的，经常需要拆除设备，增加医疗保健成本，对生活质量产生负面影响，同时还使癌症治疗复杂化，通常导致进一步的挽救生命的癌症治疗延迟。在此，作者全面回顾了多种基于证据的建议以及最佳实践、专家意见和新颖方法，以预防不同的与设备相关的感染。作者以系统的方式提出了许多预防这些感染的通用原则，然后是特定的设备相关建议。持续参与和有意义的合作，包括监管机构、行业、专科医学学会、医院和感染控制目标干预以及基本医疗保健和咨询医疗保健提供者，对于持续减少这些可预防感染的发生率非常重要。© 2022 The Authors. CA: A Cancer Journal for Clinicians由Wiley Periodicals LLC代表美国癌症协会出版。

Over the past several years, multifaceted advances in the management of cancer have led to a significant improvement in survival rates. Throughout patients' oncological journeys, they will likely receive one or more implantable devices for the administration of fluids and medications as well as management of various comorbidities and complications related to cancer therapy. Infections associated with these devices are frequent and complex, often necessitating device removal, increasing health care costs, negatively affecting quality of life, and complicating oncological care, usually leading to delays in further life-saving cancer therapy. Herein, the authors comprehensively review multiple evidence-based recommendations along with best practices, expert opinions, and novel approaches for the prevention of diverse device-related infections. The authors present many general principles for the prevention of these infections followed by specific device-related recommendations in a systematic manner. The continuous involvement and meaningful cooperation between regulatory entities, industry, specialty medical societies, hospitals, and infection control-targeted interventions, along with primary care and consulting health care providers, are all vital for the sustained reduction in the incidence of these preventable infections.© 2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.